Advances in Screening for Radiation-Associated Cardiotoxicity in Cancer Patients

Keyphrases

• Biomarker Strategy 50%
• Biomarker Testing 50%
• Cancer Patients 100%
• Cancer Treatment 50%
• Cardiac Echocardiography 50%
• Cardiotoxicity 100%
• Cardiovascular Effects 100%
• Computed Tomography 50%
• Early Detection 50%
• Early Intervention 50%
• Galectin-3 (Gal-3) 50%
• Growth Differentiation factor-15 (GDF-15) 50%
• Imaging Applications 50%
• Imaging Biomarkers 50%
• Imaging Parameters 50%
• Imaging Screen 50%
• In Cancer 100%
• Initial Screening Tests 50%
• Late Effects 50%
• Magnetic Resonance Imaging 100%
• Metabolomics 50%
• MicroRNA 50%
• Myeloperoxidase 50%
• Natriuretic Peptides 50%
• Novel Imaging 50%
• Optimal Imaging 50%
• Overall Survival 50%
• Parameter Test 50%
• Positron Emission Tomography 50%
• Radiation Effects 50%
• Radiation Therapy 50%
• Radiation-associated 100%
• Screening Modality 50%
• Surveillance Strategy 50%
• Treatment Initiation 50%
• Troponin 50%

Medicine and Dentistry

• Biological Marker 100%
• Cancer Treatment 33%
• Cardiac Finding 33%
• Cardiotoxicity 100%
• Cardiovascular Effect 66%
• Computer Assisted Tomography 33%
• Early Intervention 33%
• Echocardiography 33%
• Galectin 3 33%
• Growth Differentiation Factor 15 33%
• Late Effect 33%
• Magnetic Resonance Imaging 66%
• Malignant Neoplasm 100%
• Metabolomics 33%
• microRNA 33%
• Myeloperoxidase 33%
• Natriuretic Factor 33%
• Overall Survival 33%
• Positron Emission Tomography 33%
• Radiation Therapy 33%
• Screening Test 33%
• Troponin 33%